#IDMastodon#cancercare Annual #covid19vaccine boosting for patients undergoing #antineoplasticcancer treatments reduced risks for targeted or hormonal treatments, immunotherapy, and chemotherapy-immunotherapy combinations similarly to the general population. Patients receiving no treatment or #chemotherapy exhibited higher risks, suggesting that accelerated vaccination schedules should be considered. Patients treated with #rituximab therapy posed the highest infection risk .
